Work

A Truncation Mutant of CSF3R, Identified As a Novel Driver in De Novo Myeloid Leukemia, Signals Through TNK2, and Is Responsive to Dasatinib.

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.2412.2412

Authors: Julia E Maxson, Jason Gotlib, Angela G. Fleischman, Christopher A. Eide, Daniel Bottomly, Beth Wilmot, Shannon McWeeney, Cristina Tognon, Marc M Loriaux, Brian J. Druker, Jeffrey W Tyner

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, Stanford Medicine, Stanford University, Howard Hughes Medical Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980145345

FWCI: 0.211

Cites:

Cited by: 1

Related to: 10